Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
Submitted by
admin
on November 14, 2018 - 11:37am
Source:
CP Wire
News Tags:
Bayer
regorafenib
glioblastoma
Headline:
Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
snippet:
GBM AGILE is backed by more than 150 collaborators around the world
GBM treatment options and patient outcomes have remained largely unchanged over several decades and there is no known cure
Do Not Allow Advertisers to Use My Personal information
